SML1657

Gefitinib

≥98% (HPLC), powder, EGFR TK inhibitor

• Synonyme(s) : N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine, ZD1839
• Formule empirique (notation de Hill) : C₂₂H₂₄ClFN₄O₃
• Numéro CAS: 184475-35-2
• Poids moléculaire : 446.90
• UNSPSC Code: 12352200
• PubChem Substance ID: 329825996
• NACRES: NA.77
• MDL number: MFCD04307832
• Assay: ≥98% (HPLC)
• Form: powder

Propriétés

• Nom du produit: Gefitinib, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 10 mg/mL, clear
• storage temp.: room temp
• SMILES string: COC(C=C(N=CN=C1NC2=CC(Cl)=C(F)C=C2)C1=C3)=C3OCCCN4CCOCC4
• InChI: 1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
• InChI key: XGALLCVXEZPNRQ-UHFFFAOYSA-N
• Gene Information: human ... EGFR(1956)

Description

Application

Gefitinib has been used :

• To study its effective use in endometrial cancer therapy
• Cell proliferation, cell cycle and apoptosis assays
• Cell viability assay and colony formation assay

Biochem/physiol Actions

Gefitinib is a selective epidermal growth factor receptor tyrosine kinase (EGFR TK) inhibitor. Gefitinib has antineoplastic activity, and has been approved for the treatment on non-small cell lung cancer (NSCLC).
Gefitinib has a higher affinity for ATP (adenosine triphosphate) binding site in the EGFR tyrosine kinase domain than ATP. Hence, gefitinib is known to inhibit the progression of endometrial cancer.

Informations sur la sécurité

• Pictogrammes: GHS08,GHS05,GHS07,GHS09
• Mot-clé: Danger
• Codes de danger: H302,H315,H318,H351,H360Fd,H373,H410
• Mentions de précaution: P273 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 1 - Carc. 2 - Eye Dam. 1 - Repr. 1B - Skin Irrit. 2 - STOT RE 2 Oral
• Classe de stockage: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• Que se passe-t-il ?: WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable